Literature DB >> 32405061

IL-8 and cancer prognosis on immunotherapy.

Ziad Bakouny1, Toni K Choueiri2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32405061     DOI： 10.1038/s41591-020-0873-9

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  28 in total

1.  Alignment of practices for data harmonization across multi-center cell therapy trials: a report from the Consortium for Pediatric Cellular Immunotherapy.

Authors:  Hisham Abdel-Azim; Hema Dave; Kimberly Jordan; Stephanie Rawlings-Rhea; Annie Luong; Ashley L Wilson
Journal:  Cytotherapy       Date:  2021-10-26       Impact factor: 5.414

2.  IFNγ induces JAK1/STAT1/p65 NFκB-dependent interleukin-8 expression in ovarian cancer cells, resulting in their increased migration.

Authors:  Sveta Padmanabhan; Bijaya Gaire; Yue Zou; Mohammad M Uddin; Daniel DeLeon; Ivana Vancurova
Journal:  Int J Biochem Cell Biol       Date:  2021-10-06       Impact factor: 5.085

Review 3.  Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinoma.

Authors:  David A Braun; Ziad Bakouny; Laure Hirsch; Ronan Flippot; Eliezer M Van Allen; Catherine J Wu; Toni K Choueiri
Journal:  Nat Rev Clin Oncol       Date:  2021-01-12       Impact factor: 66.675

Review 4.  Interleukins in cancer: from biology to therapy.

Authors:  Daria Briukhovetska; Janina Dörr; Stefan Endres; Peter Libby; Charles A Dinarello; Sebastian Kobold
Journal:  Nat Rev Cancer       Date:  2021-06-03       Impact factor: 69.800

Review 5.  The role of tumor heterogeneity in immune-tumor interactions.

Authors:  Shelby M Knoche; Alaina C Larson; Bailee H Sliker; Brittany J Poelaert; Joyce C Solheim
Journal:  Cancer Metastasis Rev       Date:  2021-03-08       Impact factor: 9.237

6.  Extract from the Coriolus versicolor Fungus as an Anti-Inflammatory Agent with Cytotoxic Properties against Endothelial Cells and Breast Cancer Cells.

Authors:  Tomasz Jędrzejewski; Justyna Sobocińska; Małgorzata Pawlikowska; Artur Dzialuk; Sylwia Wrotek
Journal:  Int J Mol Sci       Date:  2020-11-28       Impact factor: 5.923

7.  Enhanced antitumoral activity of TLR7 agonists via activation of human endogenous retroviruses by HDAC inhibitors.

Authors:  David Díaz-Carballo; Sahitya Saka; Ali H Acikelli; Ekaterina Homp; Julia Erwes; Rebecca Demmig; Jacqueline Klein; Katrin Schröer; Sascha Malak; Flevy D'Souza; Adrien Noa-Bolaño; Saskia Menze; Emilio Pano; Swetlana Andrioff; Marc Teipel; Philip Dammann; Diana Klein; Amber Nasreen; Andrea Tannapfel; Nicole Grandi; Enzo Tramontano; Crista Ochsenfarth; Dirk Strumberg
Journal:  Commun Biol       Date:  2021-03-03

Review 8.  Next generation of immune checkpoint inhibitors and beyond.

Authors:  Julian A Marin-Acevedo; ErinMarie O Kimbrough; Yanyan Lou
Journal:  J Hematol Oncol       Date:  2021-03-19       Impact factor: 17.388

9.  Cytokine Profiling of End Stage Cancer Patients Treated with Immunotherapy.

Authors:  Marco Carlo Merlano; Andrea Abbona; Matteo Paccagnella; Antonella Falletta; Cristina Granetto; Vincenzo Ricci; Elena Fea; Nerina Denaro; Fiorella Ruatta; Anna Merlotti; Oscar Bertetto; Nicola Crosetto; Danilo Galizia; Marco Basiricò; Loretta Gammaitoni; Dario Sangiolo; Massimo Aglietta; Ornella Garrone
Journal:  Vaccines (Basel)       Date:  2021-03-08

10.  Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma.

Authors:  Alexander Chehrazi-Raffle; Luis Meza; Marice Alcantara; Nazli Dizman; Paulo Bergerot; Nicholas Salgia; JoAnn Hsu; Nora Ruel; Sabrina Salgia; Jasnoor Malhotra; Ewa Karczewska; Marcin Kortylewski; Sumanta Pal
Journal:  J Immunother Cancer       Date:  2021-03       Impact factor: 13.751
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.